Extra-articular Manifestations in Rheumatoid Arthritis
- PMID: 21977172
- PMCID: PMC3152850
Extra-articular Manifestations in Rheumatoid Arthritis
Abstract
Rheumatoid arthritis (RA) is a systemic autoimmune disease whose main characteristic is persistent joint inflammation that results in joint damage and loss of function.Although RA is more common in females, extra-articular manifestations of the disease are more common in males. The extra-articular manifestations of RA can occur at any age after onset. It is characterised by destructive polyarthritis and extra-articular organ involvement, including the skin, eye, heart, lung, renal, nervous and gastrointestinal systems. The frequence of extra-articular manifestations in RA differs from one country to another. Extra-articular organ involvement in RA is more frequently seen in patients with severe, active disease and is associated with increased mortality. Incidence and frequence figures for extra-articular RA vary according to study design. Extra-articular involvement is more likely in those who have RF and/or are HLA-DR4 positive. Occasionally, there are also systemic manifestations such as vasculitis, visceral nodules, Sjögren's syndrome, or pulmonary fibrosis present. Nodules are the most common extra-articular feature, and are present in up to 30%; many of the other classic features occur in 1% or less in normal clinic settings. Sjögren's syndrome, anaemia of chronic disease and pulmonary manifestations are relatively common - in 6-10%, are frequently present in early disease and are all related to worse outcomes measures of rheumatoid disease in particular functional impairment and mortality. The occurrence of these systemic manifestations is a major predictor of mortality in patients with RA.This paper focuses on extra-articular manifestations, defined as diseases and symptoms not directly related to the locomotor system.
Keywords: extra-articular manifestations; rheumatoid arthritis.
Similar articles
-
Extra-articular manifestations and complications of rheumatoid arthritis.Best Pract Res Clin Rheumatol. 2007 Oct;21(5):907-27. doi: 10.1016/j.berh.2007.05.007. Best Pract Res Clin Rheumatol. 2007. PMID: 17870035 Review.
-
Beyond the joints, the extra-articular manifestations in rheumatoid arthritis.Autoimmun Rev. 2021 Feb;20(2):102735. doi: 10.1016/j.autrev.2020.102735. Epub 2020 Dec 17. Autoimmun Rev. 2021. PMID: 33346115 Review.
-
The clinical features of rheumatoid arthritis.Eur J Radiol. 1998 May;27 Suppl 1:S18-24. doi: 10.1016/s0720-048x(98)00038-2. Eur J Radiol. 1998. PMID: 9652497 Review.
-
Raised IgA rheumatoid factor (RF) but not IgM RF or IgG RF is associated with extra-articular manifestations in rheumatoid arthritis.Scand J Rheumatol. 1995;24(6):372-5. doi: 10.3109/03009749509095183. Scand J Rheumatol. 1995. PMID: 8610222
-
Extra-articular manifestations are uncommon in southern Chinese with rheumatoid arthritis.Br J Rheumatol. 1993 Mar;32(3):209-11. doi: 10.1093/rheumatology/32.3.209. Br J Rheumatol. 1993. PMID: 8448610
Cited by
-
Comorbidity profile among patients with rheumatoid arthritis and the impact on prescriptions trend.Clin Med Insights Arthritis Musculoskelet Disord. 2013 Apr 4;6:11-8. doi: 10.4137/CMAMD.S11481. Print 2013. Clin Med Insights Arthritis Musculoskelet Disord. 2013. PMID: 23645988 Free PMC article.
-
Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022.J Clin Med. 2022 May 11;11(10):2704. doi: 10.3390/jcm11102704. J Clin Med. 2022. PMID: 35628831 Free PMC article. Review.
-
Gut Microbial Composition and Function Are Altered in Patients with Early Rheumatoid Arthritis.J Clin Med. 2019 May 16;8(5):693. doi: 10.3390/jcm8050693. J Clin Med. 2019. PMID: 31100891 Free PMC article.
-
Methotrexate revisited: considerations for subcutaneous administration in RA.Clin Rheumatol. 2015 Feb;34(2):201-5. doi: 10.1007/s10067-014-2830-9. Epub 2014 Nov 30. Clin Rheumatol. 2015. PMID: 25433918 Review.
-
Anti-inflammatory and antioxidant effect of Kerabala: a value-added ayurvedic formulation from virgin coconut oil inhibits pathogenesis in adjuvant-induced arthritis.Inflammopharmacology. 2017 Feb;25(1):41-53. doi: 10.1007/s10787-016-0298-8. Epub 2016 Nov 22. Inflammopharmacology. 2017. PMID: 27878500
References
-
- Turesson C, Matterson EL. Management of extra-articular disease manifestations in rheumatoid arthritis. Curr Opin Rheumatol. 2004;16(3):206–211. - PubMed
-
- Mielants H, Van den Bosch F. Extra-articular manifestations. Clin Exp Rheumatology. 2009;27(Suppl 55):S56–S61. - PubMed
-
- Crostein BN. Interleukin-6 – a key mediator of systemic and local symptoms in rheumatoid arthritis. Bull NYU Hosp J Dis. 2007;65(Suppl 1):S11–S15. - PubMed
-
- Bongartz T, Cantaert T, Atkins SR, et al. Cirullination in extra-articular manifestations of rheumatoid arthritis. Rheumatol (Oxford) 2007;46(1):70–75. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials